Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Clinical Trial ID NCT00005634

PubWeight™ 1.59‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00005634

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Targeting Histone Deacetylases in Diseases: Where Are We? Antioxid Redox Signal 2014 0.88
2 Epigenetic modulators as therapeutic targets in prostate cancer. Clin Epigenetics 2016 0.76
Next 100